Cargando…

Prediction and Verification of Potential Therapeutic Targets for Non-Responders to Infliximab in Ulcerative Colitis

BACKGROUND: Infliximab (IFX) has been widely used in ulcerative colitis (UC) patients. However, the subsequent effective treatment of IFX non-response in UC patients remains a challenge. This study aims to predict potential therapeutic targets for non-responders by performing a bioinformatic analysi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lyu, Xue, Zhang, Zhe, Liu, Xia, Geng, Li, Zhang, Muhan, Feng, Baisui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198282/ https://www.ncbi.nlm.nih.gov/pubmed/37215377 http://dx.doi.org/10.2147/JIR.S409290

Ejemplares similares

Proteomic Analysis of Potential Targets for Non-Response to Infliximab in Patients With Ulcerative Colitis
por: Liu, Lu, et al.
Publicado: (2022)

Pediatric Ulcerative Colitis: The Therapeutic Road to Infliximab
por: Puthoor, Pamela R., et al.
Publicado: (2013)

Infliximab in ulcerative colitis
por: Levin, Avi, et al.
Publicado: (2008)

Therapeutic Drug Monitoring of Infliximab in Acute Severe Ulcerative Colitis
por: Gordon, Benjamin L., et al.
Publicado: (2023)

Long-Term Risk of Colectomy in Patients with Severe Ulcerative Colitis Responding to Intravenous Corticosteroids or Infliximab
por: De Cristofaro, Elena, et al.
Publicado: (2022)

The Effect of Infliximab on Patients with Ulcerative Colitis in Korea
por: Seo, Hyun Il, et al.
Publicado: (2014)

Infliximab is effective in the treatment of ulcerative colitis with dermatomyositis: A case report
por: Huang, Bin-Bin, et al.
Publicado: (2020)

Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
por: Xie, Feng, et al.
Publicado: (2009)

Infliximab: the evidence for its place in therapy in ulcerative colitis
por: Van Assche, Gert, et al.
Publicado: (2007)

Promising effect of infliximab on the extent of involvement in ulcerative colitis
por: Adibi, Peyman, et al.
Publicado: (2011)

Cause for controversy? Infliximab in the treatment of ulcerative colitis: an update
por: Lawlor, Garrett, et al.
Publicado: (2009)

Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis
por: Fasanmade, Adedigbo A., et al.
Publicado: (2009)

Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis
por: Mirza, Muhammad, et al.
Publicado: (2018)

Early Serum Infliximab Levels in Pediatric Ulcerative Colitis
por: deBruyn, Jennifer C. C., et al.
Publicado: (2021)

Tracheobronchitis in ulcerative colitis: a case report of therapeutic response with infliximab and review of the literature
por: Horgan, Lisa, et al.
Publicado: (2019)

Case Report: Unusual Cause of Fever in Ulcerative Colitis Treated with Infliximab
por: Sha, Sumei, et al.
Publicado: (2023)

Autoimmune hemolytic anemia associated with infliximab infusion in ulcerative colitis
por: Mir, Fazia A., et al.
Publicado: (2018)

Listeria Meningitis during Infliximab-based Treatment for Ulcerative Colitis
por: Tsuchiya, Atsunori, et al.
Publicado: (2018)

Infliximab versus Adalimumab, Which One Is Better for Ulcerative Colitis?
por: Kim, Eun Soo
Publicado: (2021)

Vedolizumab is superior to infliximab in biologic naïve patients with ulcerative colitis
por: Sablich, Renato, et al.
Publicado: (2023)

The Degree of Ulcerative Colitis Burden of Luminal Inflammation score is superior to predicting medium- to long-term prognosis in patients with active ulcerative colitis
por: Chen, Liang, et al.
Publicado: (2020)

Calprotectin and the Magnitude of Antibodies to Infliximab in Clinically-stable Ulcerative Colitis Patients are More Relevant Than Infliximab Trough Levels and Pharmacokinetics for Therapeutic Escalation
por: Magro, Fernando, et al.
Publicado: (2017)

Pediatric ulcerative colitis: current treatment approaches including role of infliximab
por: Bradley, Gia M, et al.
Publicado: (2012)

Cost-Effectiveness of Infliximab for the Treatment of Acute Exacerbations of Ulcerative Colitis in the Netherlands
por: Chaudhary, Mohammad A., et al.
Publicado: (2012)

Linear IgA dermatosis after infliximab infusion for ulcerative colitis
por: Bryant, Kelli D., et al.
Publicado: (2016)

An indirect comparison of infliximab versus adalimumab or golimumab for active ulcerative colitis
por: Kawalec, Paweł, et al.
Publicado: (2016)

Neutrophil-to-Lymphocyte Ratio for Predicting Loss of Response to Infliximab in Ulcerative Colitis
por: Nishida, Yu, et al.
Publicado: (2017)

Disseminated Nocardiosis Associated with Treatment with Infliximab in a Patient with Ulcerative Colitis
por: Garner, Orlando, et al.
Publicado: (2017)

Pooled analysis of the comparative efficacy between tacrolimus and infliximab for ulcerative colitis
por: Liu, Yi-Juan, et al.
Publicado: (2018)

Sarcoidosis associated with infliximab therapy in ulcerative colitis: A case report
por: Gîlcă, Georgiana-Emmanuela, et al.
Publicado: (2017)

Has infliximab influenced the course and prognosis of acute severe ulcerative colitis?
por: Viscido, Angelo, et al.
Publicado: (2019)

Efficacy of infliximab, cyclosporine and tacrolimus on ulcerative colitis: A meta-analysis
por: Jia, Xuemei, et al.
Publicado: (2020)

Tumor necrosis factor-mediated disposition of infliximab in ulcerative colitis patients
por: Berends, Sophie E., et al.
Publicado: (2019)

De novo ulcerative colitis after kidney transplantation treated with infliximab
por: Oki, Rikako, et al.
Publicado: (2021)

Ramsay Hunt Syndrome in a Patient with Ulcerative Colitis Treated with Infliximab
por: Gaudêncio, Margarida, et al.
Publicado: (2021)

Capsule endoscopy with retention of 4 years: A case report
por: Chen, Hongchao, et al.
Publicado: (2022)

Effectiveness of infliximab in the treatment of perianal fistulas in ulcerative colitis: report of two cases
por: de la Piscina, Patricia Ramírez, et al.
Publicado: (2013)

Listeria meningitis and resultant symptomatic hydrocephalus complicating infliximab treatment for ulcerative colitis
por: Rana, Fahd, et al.
Publicado: (2014)

Infliximab-associated fulminant hepatic failure in ulcerative colitis: a case report
por: Parra, Rogerio Serafim, et al.
Publicado: (2015)

Febrile Neutropenia with Thrombocytopenia after Infliximab Induction in a Patient with Ulcerative Colitis
por: Gomez, Gustavo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_otv631tqvtdfnsjun8merrumvr